• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Why and when startups should look to diverse sources of capital

October 3, 2021 by David Barret Leave a Comment

Venture capital is a popular source of capital for early-stage startups, but it’s definitely not the only one. Debt is an increasingly popular alternative, as is non-dilutive, revenue-based financing.

So, we invited Accel Partner Arun Mathew, Clearco co-founder and president Michele Romanow, and Pipe co-founder and co-CEO Harry Hurst to TechCrunch Disrupt 2021 last week to discuss the various ways companies can raise capital and which might be the best avenue for startups. (Hurst unfortunately had a power outage so was not available for the entirety of the panel).

Both Clearco and Pipe offer revenue-based financing and both have raised large sums of venture capital themselves, some might say ironically. But Romanow and Hurst were emphatic in their belief that venture funding and other forms of capital don’t have to be “mutually exclusive.” 

“I actually think the biggest companies in our portfolio are broadly using multiple, different pools of capital,” Romanow said. “I would encourage you to do your research on what type of capital is good for which particular stage of the company you’re in, and which particular purpose you’re using it for. And if you do that, I think you’ll find that you’ll end up being a lot less diluted at the end of the day. And you’ll actually find more leverage over time that will allow you to scale a lot faster.”

Mathew argued that the majority of startups are actually not a great fit for venture investment. “Venture investment is expensive, and depending on who you raise from, it comes associated with certain expectations,” he said. 

Romanow pointed out that whether or not a founder should opt for venture capital or other types of financing largely depends on what they are planning to use the money for. For example, if a startup were looking for capital to spend on inventory and advertising, then venture dollars wouldn’t be the best fit. “It really doesn’t make sense to give up valuable equity at an early stage to do something that’s a repeatable and scalable expense with a fixed return,” Romanow said.

Source Link Why and when startups should look to diverse sources of capital

David Barret
David Barret

Related posts:

  1. Soccer-Pepi impresses on debut as U.S. beat Honduras 4-1 in World Cup qualifier
  2. Exclusive-Dubai courier Aramex in talks to buy Turkey’s MNG Kargo -sources
  3. Flite Material Sciences uses lasers, not chemical coatings, to keep ice and rust off surfaces
  4. Fed to release paper on central bank digital currency soon, Powell says

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Answer To 30-Year-Old Mystery Code Embedded In The Kryptos CIA Sculpture To Be Sold At Auction
  • Merry Mice: Human Brain Cells Transplanted Into Mice Reduce Anxiety And Depression
  • Asteroid-Bound NASA Mission Snaps Earth-Moon Portrait From 290 Million Kilometers Away
  • Forget State Mammals – Some States Have Official Dinosaurs, And They’re Awesome
  • Female Jumping Spiders Of Two Species Prefer The Sexy Red Males Of One, Leading To Hybridization
  • Why Is It So Difficult To Find New Moons In The Solar System?
  • New “Oxygen-Breathing” Crystal Could Recharge Fuel Cells And More
  • Some Gut Bacteria Cause Insomnia While Others Protect Against It, 400,000-Person Study Argues
  • Neanderthals And Homo Sapiens Got It On 100,000 Years Earlier Than We Thought
  • “Womb Of The Universe”: Native American Tribal Elders Help Archaeologists Decipher Ancient Rock Art In Missouri Cave
  • 16,000-Year-Old Paintings Suggest Prehistoric Humans Risked Their Lives To Enter “Shaman Training Cave”
  • Final Gasps Of A Dying Star Seen Through A Record-Breaking 130 Years Of Data
  • COVID-19 “Vaccine Alternative” Injection Could Be On Fast-Track To Approval From FDA
  • New Jersey Officials Investigate Possible First Locally Acquired Malaria Case Since 1991
  • First-of-Its-Kind Bright Orange Nurse Shark Recorded Off Costa Rica Makes History
  • JWST Spots Tiny New Moon Just Outside Uranus’s Rings, Bringing Total to 29
  • New Fossil Trackways Reveal Fish Left The Ocean 10 Million Years Earlier Than Thought
  • Thousands Of Bumblebee Catfish Seen Literally Climbing The Walls For The First Time Ever
  • Massive Hydrogen-Rich Hydrothermal System Discovered In Pacific 100 Times Larger Than Atlantic’s “Lost City”
  • World’s Driest Hot Desert Set To See Major Desert Bloom Next Month, The First Since 2022
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version